These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 15364062)

  • 21. Drug discovery and development in the field of cardiovascular disease. An interview with Dr William Greenlee by Alexandra Hemsley.
    Greenlee W
    Future Med Chem; 2013 Mar; 5(4):375-6. PubMed ID: 23495683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting telomerase and telomeres: a click chemistry approach towards highly selective G-quadruplex ligands.
    Moorhouse AD; Haider S; Gunaratnam M; Munnur D; Neidle S; Moses JE
    Mol Biosyst; 2008 Jun; 4(6):629-42. PubMed ID: 18493662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interview with Johann de Bono for Future Oncology. Interviewed by Francesca Lake.
    de Bono J
    Future Oncol; 2012 Nov; 8(11):1381-2. PubMed ID: 23148611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interview with Future Medicinal Chemistry's US Senior Editor, Iwao Ojima. Interview by Issac Bruce.
    Ojima I
    Future Med Chem; 2012 Oct; 4(16):2019-22. PubMed ID: 23157234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluorescence-based melting assays for studying quadruplex ligands.
    De Cian A; Guittat L; Kaiser M; Saccà B; Amrane S; Bourdoncle A; Alberti P; Teulade-Fichou MP; Lacroix L; Mergny JL
    Methods; 2007 Jun; 42(2):183-95. PubMed ID: 17472900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New highly hydrosoluble and not self-aggregated perylene derivatives with three and four polar side-chains as G-quadruplex telomere targeting agents and telomerase inhibitors.
    Franceschin M; Pascucci E; Alvino A; D'Ambrosio D; Bianco A; Ortaggi G; Savino M
    Bioorg Med Chem Lett; 2007 May; 17(9):2515-22. PubMed ID: 17317176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Affinity and selectivity of G4 ligands measured by FRET.
    De Cian A; Guittat L; Shin-ya K; Riou JF; Mergny JL
    Nucleic Acids Symp Ser (Oxf); 2005; (49):235-6. PubMed ID: 17150720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The recognition of higher-order G-quadruplex by chiral cyclic-helicene molecules.
    Xu Y; Yamazaki S; Osuga H; Sugiyama H
    Nucleic Acids Symp Ser (Oxf); 2006; (50):183-4. PubMed ID: 17150878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interview with Frank Ivy Carroll.
    Carroll FI; Coaker H
    Future Med Chem; 2013 Jun; 5(10):1083-8. PubMed ID: 23795966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The bioprocessing of stem cells: how to reach the clinic. Interviewed by Emily Culme-Seymour.
    Zandstra P
    Regen Med; 2013 Jul; 8(4):409-12. PubMed ID: 23826695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interview: Interview with Professor Malcolm Rowland.
    Rowland M
    Bioanalysis; 2010 Mar; 2(3):385-91. PubMed ID: 21083248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studying microbial pathogenesis and bacterial diseases. Interview by Hannah Branch.
    Finlay BB
    Future Microbiol; 2013 Jun; 8(6):709-10. PubMed ID: 23701328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the bridge over the translational valley of death: interview with Per I Arvidsson.
    Arvidsson PI
    Future Sci OA; 2017 Jun; 3(2):FSO183. PubMed ID: 28670474
    [No Abstract]   [Full Text] [Related]  

  • 34. A combined QM and MM investigation into guanine quadruplexes.
    Clay EH; Gould IR
    J Mol Graph Model; 2005 Oct; 24(2):138-46. PubMed ID: 16168688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amide bond direction modulates G-quadruplex recognition and telomerase inhibition by 2,6 and 2,7 bis-substituted anthracenedione derivatives.
    Zagotto G; Sissi C; Moro S; Dal Ben D; Parkinson GN; Fox KR; Neidle S; Palumbo M
    Bioorg Med Chem; 2008 Jan; 16(1):354-61. PubMed ID: 17936629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benzo(h)quinoline derivatives as G-quadruplex binding agents.
    Paritala H; Firestine SM
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1584-7. PubMed ID: 19243943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transitioning biomarkers into the clinic.
    Waldman SA
    Expert Rev Clin Pharmacol; 2009 Jan; 2(1):9-13. PubMed ID: 24422768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. G-quadruplex preferentially forms at the very 3' end of vertebrate telomeric DNA.
    Tang J; Kan ZY; Yao Y; Wang Q; Hao YH; Tan Z
    Nucleic Acids Res; 2008 Mar; 36(4):1200-8. PubMed ID: 18158301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced or diminished stabilization of the telomere G-quadruplex and inhibition of telomerase by small chemical ligands under molecular crowding condition.
    Chen Z; Zheng KW; Hao YH; Tan Z
    J Am Chem Soc; 2009 Aug; 131(30):10430-8. PubMed ID: 19588966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.